Insmed Inc is a biopharmaceutical company. The Company is developing ARIKAYCE for inhalation (LAI), for patients with nontuberculous mycobacteria lung disease, a rare and often chronic infection that is capable of causing irreversible lung damage.
| Website: | www.insmed.com |
| Email: | afields@lhai.com |
| Main Phone: | +1 908 977-9900 |
| Address: | 10 Finderne Avenue |
| Address 2: | Building 10 |
| State: | NJ |
| City / Town: | Bridgewater |
| Country: | USA |
| Postal Code: | 08807 |
| Exchange: | NGS |
| Employees: | 125 |
| NAICS: | Pharmaceutical P |
| Last Price 16.07 | Change $ -1.07 | Change % -6.24 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 17.01 | High 17.01 | Low 16.05 | Prev Close 17.14 |
| Last Trade | Volume 523,677 | 52 Wk Hi 19.35 | 52 Wk Low 9.02 |
| Market Cap 997.8 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 62,090,141.00 | EPS (TTM) -2.91 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 4 |
| Number of Buys | 0 | 2 |
| Number of Sells | 0 | 2 |
| Net Activity | 0 | 25244 |
| Last 10 Buys | Shares |
|---|---|
| William Lewis | 1,000 |
| Melvin Sharoky | 1,000 |
| William Lewis | 1,000 |
| William Lewis | 1,000 |
| William Lewis | 1,000 |
| William Lewis | 1,000 |
| William Lewis | 1,000 |
| William Lewis | 1,000 |
| Timothy G. Whitten | 1,000 |
| Melvin Sharoky | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Donald J. Hayden | 1,000 |
| Donald J. Hayden | 1,000 |
| Mark Quigley | 1,000 |
| Mark Quigley | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 35 | 35 | 35 | 35 |
| Low Target Price Estimate | 18 | 18 | 18 | 18 |
| Mean Target Price Estimate | 24.2 | 24.2 | 24.2 | 24.2 |
| Standard Deviation | 6.46 | 6.46 | 6.46 | 6.46 |
| Date of Most Recent Estimate | 08/04/16 | 08/04/16 | 06/14/16 | 08/12/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 9 | 2016-08-04 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 164 | 2016-08-04 |
| CT ORDER | 1 | 2016-06-23 | |
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2016-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-05-23 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.33 | 1.33 | 1.33 | 1.33 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
